McKinley Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-77,737
Closed -$20.8M 513
2016
Q1
$20.8M Sell
77,737
-32,192
-29% -$9.22M 1.01% 28
2015
Q4
$34.4M Sell
109,929
-14,830
-12% -$4.42M 1.59% 12
2015
Q3
$33.9M Sell
124,759
-6,533
-5% -$2.01M 1.65% 9
2015
Q2
$39.8M Buy
+131,292
New +$39.2M 1.71% 6
2014
Q2
Sell
-271
Closed -$56K 391
2014
Q1
$56K Hold
271
﹤0.01% 339
2013
Q4
$46K Sell
271
-1
-0.4% -$156 ﹤0.01% 380
2013
Q3
$39K Sell
272
-81,705
-100% -$10.9M ﹤0.01% 342
2013
Q2
$10.3M Buy
+81,977
New +$9.28M 0.52% 53

Other funds holding AGN

McKinley Capital Management's AGN Position: Q2 2016 in Review

McKinley Capital Management sold out of Allergan plc (AGN) in Q2 2016, closing a stake of 77,737 shares — an estimated $20.8M sold.

McKinley Capital Management first reported a position in AGN in Q2 2013 and held it in 8 quarters. The position peaked at $39.8M in Q2 2015. 1,107 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

  • McKinley Capital Management reported no remaining Allergan plc position as of Q2 2016 after selling out during the quarter.
  • McKinley Capital Management sold 77,737 Allergan plc shares in Q2 2016, an estimated $20.8M.
  • McKinley Capital Management first reported a position in Allergan plc in Q2 2013 and held it in 8 quarters.
  • McKinley Capital Management's Allergan plc position peaked at $39.8M in Q2 2015.
  • 1,107 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on McKinley Capital Management's 13F filing for Q2 2016, filed 9 Aug 2016.